Novavax rollout in Australia starts a week early

Australia will begin rolling out the Novavax COVID-19 vaccine at some general clinics, regional pharmacies and state clinics nationwide from February 14th, a week earlier than planned, targeting Australians over the age of 18. increase.

This is the first protein-based vaccine approved for Australians, allowing people who are allergic to the approved vaccine or certain ingredients used in other problems to choose alternative options.

“Protein vaccines use the non-infectious protein component of the virus produced in the laboratory. After vaccination, immune cells recognize the vaccine protein as foreign and initiate an immune response to it,” Greg said. Federal Health Minister Hunt said: statement..

Most people in Australia have already been vaccinated, and 95% of people over the age of 12 have been vaccinated at least once, but Hunt expects that number to increase with the advent of Novavax. ..

“Despite the high vaccination rates in Australia, there was a demand for protein-based formulas,” he said. “For some people, the arrival of Novavax is an additional push needed to get the first jab and start protecting against COVID-19.”

Epoch Times Photo
Health Minister Greg Hunt speaks to the media at a press conference at the Doherty Institute in Melbourne, Australia on December 14, 2021. (AAPImage / Con Chronis)

The first batch of 51 million federal-purchased Novavax arrived on Tuesday.

according to Test data, Novavax vaccine efficacy is 90.4% in adults 18 years and older. The most commonly observed side effects were headache, myalgia, malaise, and malaise.

Novavax too announcement The vaccine was 82% effective against delta variants aged 12 to 17 years, according to new clinical trial data from 2,200 adolescents nationwide.

“Given the continued need for alternative vaccine options for COVID-19, we are encouraged by the consequences of this adolescent,” said Filip Dubovsky, Chief Medical Officer of Novavax. “The Novavax vaccine is a technology that has been differentiated into this young population given the established protein-based technologies already used in other vaccines and the positive responses demonstrated to the mutants. I believe we will offer options. “

Meanwhile, Australia’s Immunity Technical Advisory Group has updated its guidance on vaccination status.

ATAGI has moved away from the term “complete vaccination” and Australians over the age of 16 are now considered “latest” vaccinated only if they receive a booster shot.

Novavax has not been approved for booster shots, but research is currently underway in Australia.

Rebecca Chu


Rebecca Zhu is an Australian reporter based in Sydney. She focuses on Australia’s economy, property and education. Contact her at [email protected]

Posted on